Endovascular Treatment for Acute Basilar Artery Occlusion

NACompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

February 21, 2021

Primary Completion Date

January 3, 2022

Study Completion Date

April 3, 2022

Conditions
Basilar Artery OcclusionAcute Cerebrovascular AccidentStroke Due to Basilar Artery Occlusion
Interventions
PROCEDURE

endovascular treatment

For patients randomized to endovascular treatment arm, EVT has to be initiated within 12 hours of estimated time of basilar artery occlusion. If an appropriate thrombus or residual stenosis is identified, the choice of EVT strategy will be made by the treating neurointerventionalist. The endovascular procedures allowed by the steering committee include mechanical thrombectomy, intra-arterial thrombolysis, balloon angioplasty, stent implantation, or any combination of above procedures. We recommend applying ADAPT as the first choice of treatment. All mechanical thrombectomy devices for EVT, which are approved by CFDA for this purpose, are allowed in the trial.

OTHER

best medical management

best medical management

Trial Locations (1)

239300

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Hefei

All Listed Sponsors
lead

The First Affiliated Hospital of University of Science and Technology of China

OTHER

NCT04751708 - Endovascular Treatment for Acute Basilar Artery Occlusion | Biotech Hunter | Biotech Hunter